IP Library › Granted Patent US 10,653,800
Granted Patent B2
US 10,653,800 · App. 15/430,217 · Granted May 19, 2020

Oligonucleotide-based probes for detection of bacterial nucleases

Inventors: James O. McNamara, II (Iowa City, IA); Katie R. Flenker (Iowa City, IA); Lingyan Huang (Coralville, IA); Alexander R. Horswill (Iowa City, IA); Mark A. Behlke (Coralville, IA); Frank J. Hernandez (Iowa City, IA)
Assignees: University of Iowa Research Foundation; Integrated DNA Technologies, Inc.
A61K49/0054A61K49/0052C12Q1/44C12Q1/689C12Q1/6818C12Q1/6823G01N33/542G01N33/569G01N2333/922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,800
App. No.
15/430,217
Granted
May 19, 2020
Kind
B2
Abstract

The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., ribonuclease) substrates, and probes and compositions useful in detection assays.

Claims (12)

1. A probe for detecting a microbial endonuclease comprising an oligonucleotide of 2-30 nucleotides in length, a fluorophore operably linked to the oligonucleotide, and a quencher operably linked to the oligonucleotide, wherein the oligonucleotide comprises a chemically modified purine comprising a 2′ substituted sugar and is capable of being cleaved by a microbial nuclease but not by a mammalian nuclease.

2. The probe of claim 1 , wherein the oligonucleotide is 10-15 nucleotides in length.

3. The probe of claim 1 , wherein one or more of the chemically modified purines comprises a sugar selected from the group consisting of 2′-O-methyl-ribose, 2′-O-alkyl-ribose, 2′-O-allyl-ribose, 2′-S-alkyl-ribose, 2′-S-allyl-ribose, 2′-fluoro-ribose, 2′-halo-ribose, 2′-azido-ribose, carbocyclic sugar analogue, a-anomeric sugar, epimeric sugar, arabinose, xylose, lyxose, pyranose sugar, furanose sugar, and sedoheptulose, or is a 2′-O-methyl ribonucleotide, a 2′-methoxyethoxy ribonucleotide, a 2′-O-allyl ribonucleotide, a2′-O-pentyl ribonucleotide, a 2′-O-butyl ribonucleotide, 2′-fluoro-β-D-arabinonucleotide (FANA), Locked Nucleic Acid (LNA), or Unlocked Nucleic Acid (UNA).

4. The probe of claim 1 , wherein the fluorophore is selected from the group consisting of Hydroxycoumarin, Alexa fluor, Aminocoumarin, Methoxycoumarin, Cascade Blue, Pacific Blue, Pacific Orange, Lucifer yellow, Alexa fluor 430, NBD, R-Phycoerythrin (PE), PE-Cy5 conjugates, PE-Cy7 conjugates, Red 613, PerCP, Cy2, TruRed, FluorX, Fluorescein, FAM, BODIPY-FL, TET, Alexa fluor 532, HEX, TRITC, Cy3, TMR, Alexa fluor 546, Alexa fluor 555, Tamara, X-Rhodamine, Lissamine Rhodamine B, ROX, Alexa fluor 568, Cy3.5 581, Texas Red, Alexa fluor 594, Alexa fluor 633, LC red 640, Allophycocyanin (APC), Alexa fluor 633, APC-Cy7 conjugates, Cy5, Alexa fluor 660, Cy5.5, LC red 705, Alexa fluor 680, Cy7, and IRDye 800 CW.

5. The probe of claim 1 , wherein the quencher is selected from the group consisting of DDQ-I, Dabcyl, Eclipse, Iowa Black FQ, BHQ-1, QSY-7, BHQ-2, and DDQ-II.

6. The probe of claim 1 , wherein the oligonucleotide is single-stranded.

7. The probe of claim 1 , wherein the oligonucleotide comprises both RNA and DNA.

8. The probe of claim 7 , wherein the oligonucleotide comprises a DNA di-nucleotide.

9. A method of detecting a microbial infection of a sample comprising measuring fluorescence of a sample that has been contacted with a probe of claim 1 , wherein a fluorescence level that is greater than the fluorescence level of an uninfected control indicates that the sample has a microbial infection.

10. The method of claim 9 , wherein the method is performed in vivo for the detection of a microbial infection in a mammal, wherein a test fluorescence of potentially infected tissue that is greater than the fluorescence level of control tissue indicates that the sample has a microbial infection.

11. The method of claim 9 , wherein the test fluorescence level is at least 1-100% greater than the control level.

12. The method of claim 9 , wherein the fluorophore is detectable at a depth of 7-14 cm in the mammal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2018
From: MCNAMARA, JAMES O.; FLENKER, KATIE R.; HERNANDEZ, FRANK J.; HORSWILL, ALEXANDER R.
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 047232/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2018
From: HUANG, LINGYAN; BEHLKE, MARK A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 047233/0028 →
Continuity (4)
Continuation 14342338
Provisional Application 61530246 · Sep 1, 2011
Provisional Application 61593595 · Feb 1, 2012
Related Publication 20170224847A1 · Aug 10, 2017
Cited By (1)
US 12,378,612